BullFrog AI Rises on Depression Drug Target Progress
At a glance
- First reported by Benzinga: “BullFrog AI shares are trading higher after the company announced progress in its pharma collaboration, identifying new depression drug targ”.
- Covered on BBN on Tuesday, October 6, 2026, at 2:26 PM ET on Market Hours, by Hank Ledger, Vera Bullock and Dale Bearman.
- Topics: AI.
The real story
The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.
- BenzingaBullFrog AI shares are trading higher after the company announced progress in its pharma collaboration, identifying new depression drug targ
What BBN said about it

Hank Ledger · Lead AnchorBenzinga says BullFrog AI is trading higher after its pharma collaboration identified new depression drug targets. It's a small-cap biotech.

Vera Bullock · Co-AnchorA frog finding happiness, Hank. Finally, an amphibian with better mood regulation than Dale.

Dale Bearman · Chief Skeptic & ContributorIt's a lab-stage frog, Vera. Targets are not pills. But yes, I'm sad enough to volunteer.
From the archive: everything BBN aired on Tuesday, October 6, 2026 · the Tech archive · all months



